Skip to content

Effect of ciprofol and sevoflurane maintenance anesthesia on perioperative ultrasound measurements of optic nerve sheath diameter in patients in laparoscopic Trendelenburg position: a randomized controlled study

Effect of ciprofol and sevoflurane maintenance anesthesia on perioperative ultrasound measurements of optic nerve sheath diameter in patients in laparoscopic Trendelenburg position: a randomized controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500095885
Enrollment
Unknown
Registered
2025-01-15
Start date
2025-01-31
Completion date
Unknown
Last updated
2025-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer, endometrial cancer, cervical cancer, and prostate cancer, among others

Interventions

Experimental group:ciprofol was continuously pumped by 1mg/kg/h for anesthesia maintenance

Sponsors

The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age>18 years old; 2. ASA I-II; 3. Patients who intend to undergo lower abdominal and pelvic surgery under general anesthesia; 4. BMI>18kg/m2; 5. Patients or family members have a full understanding of the purpose and significance of this study, voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Those who are allergic to the drug in this test 2. Patients with a history of cerebrovascular disease and preoperative intracranial hypertension; 3. Those with eye diseases and a history of eye surgery; 4. Patients with psychiatric diseases (such as schizophrenia, depression, etc.), history of epilepsy and cognitive dysfunction; 5. Those with a history of abuse of psychotropic drugs and narcotics in the past; 6. Suffering from severe vision or hearing disorders, unable to communicate smoothly, or illiterate; 7. ASA grade III or above, such as those with uncontrolled systemic diseases such as hypertension, diabetes, hyperthyroidism, patients with severe cardiopulmonary diseases, abnormal liver function, renal function, coagulation function, etc.; 8. Participated in other drug clinical trials as a subject in the past 3 months; 9. Subjects who, in the opinion of the investigator, have any other factors that are not suitable for participating in this trial.

Design outcomes

Primary

MeasureTime frame
Optic nerve sheath diameter;

Secondary

MeasureTime frame
Postoperative recovery quality and recovery time;Postoperative cognitive dysfunction;The occurrence of adverse reactions such as eye discomfort, dizziness, headache, nausea, etc;

Countries

China

Contacts

Public ContactLiu Junpeng

The Affiliated Cancer Hospital of Zhengzhou University (Henan Cancer Hospital)

kaigoogle@163.com+86 176 3857 8575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026